Back to 
LAZARD ASSET MANAGEMENT LLC
LAZARD ASSET MANAGEMENT LLC
DBTXShowing 0 of 2 quarters
Position history for LAZARD ASSET MANAGEMENT LLC's holdings in Decibel Therapeutics Inc
No. Lazard Asset Management exited its DBTX (Decibel Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 3,970 shares worth $15,000. Lazard Asset Management first reported DBTX in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DBTX: CITADEL ADVISORS LLC, Alphabet Inc.